DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced it would report its financial results for the third quarter of 2006 on Thursday, November 2, 2006 after the close of the financial markets. The announcement will be followed by a conference call scheduled for the next morning, Friday, November 3, 2006, with the investment community at 10:00 AM EST.
